SCHEMBL14088806

SCHEMBL14088806

Cc1ccc(NC(=S)c2ccc3cccnc3n2)cc1Nc1nccc(-c2cccnc2)n1

nearest known ligand 0.67

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
ABL1 P00519 15/20 0.67
BCR P11274 13/20 0.67
PDGFRA P16234 10/20 0.67
PDGFRB P09619 6/20 0.67
PRKCA P17252 3/20 0.63
EGFR P00533 2/20 0.63
JAK3 P52333 1/20 0.63
BTK Q06187 1/20 0.63
ITK Q08881 1/20 0.63
KIT P10721 3/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4903331 0.91 ABL1 (0.54) ABL1BCRPDGFRAPDGFRBPRKCA
SCHEMBL4891578 0.90 ABL1 (0.72) ABL1BCRPDGFRAPDGFRBPRKCA
SCHEMBL4905823 0.87 ABL1 (0.63) ABL1BCRPDGFRAPDGFRBPRKCA
SCHEMBL4901315 0.82 ABL1 (0.61) ABL1BCRPDGFRAPDGFRBPRKCA
SCHEMBL23246300 0.81 ABL1 (0.86) ABL1BCRPDGFRAPDGFRBPRKCA
SCHEMBL19556857 0.80 ABL1 (1.00) ABL1BCRPDGFRAPDGFRBPRKCA
Cyclohexane SCHEMBL5776157 0.79 ABL1 (0.81) ABL1BCRPDGFRAPDGFRBPRKCA
SCHEMBL13492489 0.79 ABL1 (0.75) ABL1BCRPDGFRAPDGFRBPRKCA
SCHEMBL15159937 0.78 PRKCA (1.00) ABL1BCRPDGFRAPDGFRBPRKCA
SCHEMBL19556647 0.78 ABL1 (0.80) ABL1BCRPDGFRAPDGFRBPRKCA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080187575-A1 Pyrimidine Derivatives VICHEM CHEMIE KFT (HU) 2008-08-07 US disclosed
US-20080187575-A1 Pyrimidine Derivatives VICHEM CHEMIE KFT (HU) 2008-08-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080187575-A1 Pyrimidine Derivatives TYMP, TDP1, PNP ABL1 2843/4885BCR 2315/4885PDGFRA 373/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.